首页 > 最新文献

ISRN cardiology最新文献

英文 中文
Alcohol-attributable fraction of ischemic heart disease mortality in Russia. 俄罗斯缺血性心脏病死亡率的酒精归因比例
Pub Date : 2013-07-15 eCollection Date: 2013-01-01 DOI: 10.1155/2013/287869
Y E Razvodovsky

Objective. The aim of the present study was to estimate the premature ischemic heart disease (IHD) mortality attributable to alcohol abuse in Russia on the basis of aggregate-level data of mortality and alcohol consumption. Method. Age-standardized sex-specific male and female IHD mortality data for the period 1980-2005 and data on overall alcohol consumption were analyzed by means of autoregressive integrated moving average (ARIMA) time series analysis. Results. The results of the analysis suggest that 41.1% of all male deaths and 30.7% of female deaths from IHD in Russia could be attributed to alcohol. The estimated alcohol-attributable fraction for men ranged from 24.0% (75+ age group) to 62.0% (15-29 age group) and for women from 20.0% (75+ age group) to 64.0% (30-44 age group). Conclusions. The outcomes of this study provide indirect support for the hypothesis that the high rate of IHD mortality in Russia may be related to alcohol, as indicated by a close aggregate-level association between number of deaths from IHD and overall alcohol consumption per capita.

目标。本研究的目的是根据死亡率和酒精消费的总体数据估计俄罗斯酒精滥用导致的过早缺血性心脏病(IHD)死亡率。方法。采用自回归综合移动平均(ARIMA)时间序列分析方法分析1980-2005年期间年龄标准化、性别特异性的男性和女性IHD死亡率数据以及总体酒精消费量数据。结果。分析结果表明,俄罗斯41.1%的男性和30.7%的女性IHD死亡可归因于酒精。估计男性的酒精归因比例为24.0%(75岁以上年龄组)至62.0%(15-29岁年龄组),女性为20.0%(75岁以上年龄组)至64.0%(30-44岁年龄组)。结论。本研究的结果间接支持了俄罗斯IHD高死亡率可能与酒精有关的假设,因为IHD死亡人数与人均总饮酒量之间存在密切的总体关联。
{"title":"Alcohol-attributable fraction of ischemic heart disease mortality in Russia.","authors":"Y E Razvodovsky","doi":"10.1155/2013/287869","DOIUrl":"https://doi.org/10.1155/2013/287869","url":null,"abstract":"<p><p>Objective. The aim of the present study was to estimate the premature ischemic heart disease (IHD) mortality attributable to alcohol abuse in Russia on the basis of aggregate-level data of mortality and alcohol consumption. Method. Age-standardized sex-specific male and female IHD mortality data for the period 1980-2005 and data on overall alcohol consumption were analyzed by means of autoregressive integrated moving average (ARIMA) time series analysis. Results. The results of the analysis suggest that 41.1% of all male deaths and 30.7% of female deaths from IHD in Russia could be attributed to alcohol. The estimated alcohol-attributable fraction for men ranged from 24.0% (75+ age group) to 62.0% (15-29 age group) and for women from 20.0% (75+ age group) to 64.0% (30-44 age group). Conclusions. The outcomes of this study provide indirect support for the hypothesis that the high rate of IHD mortality in Russia may be related to alcohol, as indicated by a close aggregate-level association between number of deaths from IHD and overall alcohol consumption per capita. </p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2013 ","pages":"287869"},"PeriodicalIF":0.0,"publicationDate":"2013-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/287869","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31667655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Assessment of Risk Factor for Cardiovascular Disease Using Heart Rate Variability in Postmenopausal Women: A Comparative Study between Urban and Rural Indian Women. 使用心率变异性评估绝经后妇女心血管疾病的危险因素:印度城市和农村妇女的比较研究
Pub Date : 2013-07-11 Print Date: 2013-01-01 DOI: 10.1155/2013/858921
Nikhil Narayanaswamy, Shailaja Moodithaya, Harsha Halahalli, Amrit M Mirajkar

Cardiovascular diseases are important causes of morbidity and mortality in postmenopausal women. A major determinant of cardiovascular health is the status of autonomic nervous system and assessment of Heart Rate Variability (HRV). Heart Rate Variability is a noninvasive and sensitive technique to evaluate cardiovascular autonomic control. Reduced HRV is an independent risk factor for the development of heart disease. This study evaluated the risk factors for cardiovascular diseases using HRV, between urban and rural Indian postmenopausal women ranging in age from 40 to 75 years. Findings of the analysis of HRV have showed that the total power which reflects overall modulation of cardiac autonomic activity (759 ± 100  versus 444 ± 65), the absolute power of high frequency which is surrogate of cardiovagal activity (247 ± 41  versus 163 ± 45), and low frequency that reflects cardiac sympathetic activity (205 ± 26  versus 127 ± 18) were significantly higher in urban women than that of their rural counterparts. Further, among the anthropometric measures, waist circumference was significantly correlated with indices of HRV. The study concludes that rural Indian women are associated with an additional risk beyond that of ageing and postmenopausal status when compared to the urban women. The higher central obesity could be the contributing factor for developing higher risk for cardiovascular disease among the rural women.

心血管疾病是绝经后妇女发病和死亡的重要原因。心血管健康的主要决定因素是自主神经系统的状态和心率变异性(HRV)的评估。心率变异性是一种无创、灵敏的评价心血管自主控制的技术。HRV降低是心脏病发展的独立危险因素。本研究在印度城市和农村40 - 75岁的绝经后妇女中使用HRV评估心血管疾病的危险因素。HRV分析结果显示,反映心脏自主活动整体调节的总功率(759±100比444±65)、代表心血管活动的高频绝对功率(247±41比163±45)和反映心脏交感神经活动的低频绝对功率(205±26比127±18)在城市妇女中显著高于农村妇女。此外,在人体测量指标中,腰围与HRV指标显著相关。该研究得出的结论是,与城市妇女相比,印度农村妇女除了衰老和绝经后状态外,还存在额外的风险。较高的中心性肥胖可能是农村妇女患心血管疾病风险较高的一个因素。
{"title":"Assessment of Risk Factor for Cardiovascular Disease Using Heart Rate Variability in Postmenopausal Women: A Comparative Study between Urban and Rural Indian Women.","authors":"Nikhil Narayanaswamy,&nbsp;Shailaja Moodithaya,&nbsp;Harsha Halahalli,&nbsp;Amrit M Mirajkar","doi":"10.1155/2013/858921","DOIUrl":"https://doi.org/10.1155/2013/858921","url":null,"abstract":"<p><p>Cardiovascular diseases are important causes of morbidity and mortality in postmenopausal women. A major determinant of cardiovascular health is the status of autonomic nervous system and assessment of Heart Rate Variability (HRV). Heart Rate Variability is a noninvasive and sensitive technique to evaluate cardiovascular autonomic control. Reduced HRV is an independent risk factor for the development of heart disease. This study evaluated the risk factors for cardiovascular diseases using HRV, between urban and rural Indian postmenopausal women ranging in age from 40 to 75 years. Findings of the analysis of HRV have showed that the total power which reflects overall modulation of cardiac autonomic activity (759 ± 100  versus 444 ± 65), the absolute power of high frequency which is surrogate of cardiovagal activity (247 ± 41  versus 163 ± 45), and low frequency that reflects cardiac sympathetic activity (205 ± 26  versus 127 ± 18) were significantly higher in urban women than that of their rural counterparts. Further, among the anthropometric measures, waist circumference was significantly correlated with indices of HRV. The study concludes that rural Indian women are associated with an additional risk beyond that of ageing and postmenopausal status when compared to the urban women. The higher central obesity could be the contributing factor for developing higher risk for cardiovascular disease among the rural women. </p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2013 ","pages":"858921"},"PeriodicalIF":0.0,"publicationDate":"2013-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/858921","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31649959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Association of oral health and cardiovascular disease risk factors "results from a community based study on 5900 adult subjects". 口腔健康与心血管疾病危险因素的关联"基于5900名成人受试者的社区研究结果"。
Pub Date : 2013-07-09 eCollection Date: 2013-01-01 DOI: 10.1155/2013/782126
Hamid Najafipour, Tayebeh Malek Mohammadi, Foad Rahim, Ali Akbar Haghdoost, Mitra Shadkam, Mahdi Afshari

Objectives. This study aimed to determine the association between some oral health status as a risk factor for cardiac diseases and other cardiovascular disease (CVD) risk factors in a sample of Iranian population in 2011. Methods. The study recruited 5900 inhabitants who aged 15-75 years old of Kerman city through a population based cluster sampling. Having collected informed consent, participants were interviewed for CVD risk factors. Some oral health indicators such as DMFT, Gingival Inflammation index, and Community Periodontal Index were assessed. The association between oral health indices and CVD risk factors was tested using multivariate regression models. Results. The mean age of participants was 33.5 years, and 45.1% were male. Moderate gingival inflammation was observed in 67.6% of participants. Presence of sub- or supragingival calculus was more common (90%) in participants. Older age (RR from 2.7 to 3.88), cigarette smoking (RR = 1.49), and high blood glucose (RR = 1.41) showed an increased risk for oral diseases after adjustment for different covariates including established CVD risk factors. Conclusion. The study results showed an increase in periodontal diseases in the presence of some CVD risk factors. Therefore there may be a bilateral but independent association for both conditions and common risk factor approach preventive program is highly recommended.

目标。本研究旨在确定2011年伊朗人口样本中作为心脏病危险因素的某些口腔健康状况与其他心血管疾病(CVD)危险因素之间的关联。方法。本研究通过基于人口的整群抽样方法,招募了克尔曼市5900名年龄在15-75岁之间的居民。收集了知情同意书后,对参与者进行了心血管疾病危险因素的访谈。评估了DMFT、牙龈炎症指数、社区牙周指数等口腔健康指标。采用多元回归模型检验口腔健康指标与心血管疾病危险因素的相关性。结果。参与者的平均年龄为33.5岁,45.1%为男性。67.6%的参与者有中度牙龈炎症。龈下或龈上结石的存在在参与者中更为常见(90%)。在调整不同协变量(包括已确定的心血管疾病危险因素)后,年龄较大(RR从2.7到3.88)、吸烟(RR = 1.49)和高血糖(RR = 1.41)显示口腔疾病的风险增加。结论。研究结果显示,一些心血管疾病的危险因素会增加牙周病的发病率。因此,对于两种情况和共同的危险因素方法,可能存在双边但独立的关联,强烈建议采取预防措施。
{"title":"Association of oral health and cardiovascular disease risk factors \"results from a community based study on 5900 adult subjects\".","authors":"Hamid Najafipour,&nbsp;Tayebeh Malek Mohammadi,&nbsp;Foad Rahim,&nbsp;Ali Akbar Haghdoost,&nbsp;Mitra Shadkam,&nbsp;Mahdi Afshari","doi":"10.1155/2013/782126","DOIUrl":"https://doi.org/10.1155/2013/782126","url":null,"abstract":"<p><p>Objectives. This study aimed to determine the association between some oral health status as a risk factor for cardiac diseases and other cardiovascular disease (CVD) risk factors in a sample of Iranian population in 2011. Methods. The study recruited 5900 inhabitants who aged 15-75 years old of Kerman city through a population based cluster sampling. Having collected informed consent, participants were interviewed for CVD risk factors. Some oral health indicators such as DMFT, Gingival Inflammation index, and Community Periodontal Index were assessed. The association between oral health indices and CVD risk factors was tested using multivariate regression models. Results. The mean age of participants was 33.5 years, and 45.1% were male. Moderate gingival inflammation was observed in 67.6% of participants. Presence of sub- or supragingival calculus was more common (90%) in participants. Older age (RR from 2.7 to 3.88), cigarette smoking (RR = 1.49), and high blood glucose (RR = 1.41) showed an increased risk for oral diseases after adjustment for different covariates including established CVD risk factors. Conclusion. The study results showed an increase in periodontal diseases in the presence of some CVD risk factors. Therefore there may be a bilateral but independent association for both conditions and common risk factor approach preventive program is highly recommended. </p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2013 ","pages":"782126"},"PeriodicalIF":0.0,"publicationDate":"2013-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/782126","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31667656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Left-to-Right Shunt with Congenital Heart Disease: Single Center Experience. 先天性心脏病左向右分流:单中心经验。
Pub Date : 2013-06-23 Print Date: 2013-01-01 DOI: 10.1155/2013/301617
Ayhan Cevik, Rana Olgunturk, Serdar Kula, Berna Saylan, Ayhan Pektas, Deniz Oguz, Sedef Tunaoglu

Objective. The objective of this study was to determine the frequency of pulmonary arterial hypertension (PAH) in congenital heart disease (CHD) with an isolated, large left-to-right shunt and to indicate the factors in the development of PAH. Methods. The pressure measurements in the cardiac chambers and the calculations based on the Fick's principle were compared among 3 separate groups of patients, respectively, with PAH, with hyperkinetic pulmonary hypertension (HPH), and with neither PAH nor HPH. Results. PAH was diagnosed in 30 (12.3%) patients, HPH in 35 (14.4%), while 177 (73.1%) were free of either. The highest risk for the development of PAH was found in the presence of perimembranous ventricular septal defect. A statistically significant difference was seen among these groups as to their left atrial pressure (p = 0.005) and the mean pulmonary arterial pressure (PAPmean; p < 0.001). While a correlation was present between RpI on one hand and age on the other (p = 0.014), a multiple linear regression could not evidence any correlation among age (p = 0.321), gender (p = 0.929). Conclusion. Our findings do not allow establishing a correlation between the duration of the high pulmonary flow and pulmonary vascular resistance increase or PAH development in isolated left-to-right shunts with congenital heart diseases.

目标。本研究的目的是确定肺动脉高压(PAH)在先天性心脏病(CHD)中孤立的、大的左向右分流的频率,并指出PAH发展的因素。方法。比较3组PAH患者、HPH患者和非PAH患者的心腔压力测量和基于Fick原理的计算结果。结果。30例(12.3%)患者被诊断为PAH, 35例(14.4%)患者被诊断为HPH, 177例(73.1%)患者无PAH和HPH。发生多环芳烃的风险最高的是存在膜周围室间隔缺损。两组患者左心房压(p = 0.005)和平均肺动脉压(PAPmean;P < 0.001)。虽然RpI与年龄之间存在相关性(p = 0.014),但多元线性回归不能证明年龄(p = 0.321)和性别(p = 0.929)之间存在相关性。结论。我们的研究结果不允许在孤立的先天性心脏病左向右分流患者中建立高肺流量持续时间与肺血管阻力增加或PAH发展之间的相关性。
{"title":"Left-to-Right Shunt with Congenital Heart Disease: Single Center Experience.","authors":"Ayhan Cevik,&nbsp;Rana Olgunturk,&nbsp;Serdar Kula,&nbsp;Berna Saylan,&nbsp;Ayhan Pektas,&nbsp;Deniz Oguz,&nbsp;Sedef Tunaoglu","doi":"10.1155/2013/301617","DOIUrl":"https://doi.org/10.1155/2013/301617","url":null,"abstract":"<p><p>Objective. The objective of this study was to determine the frequency of pulmonary arterial hypertension (PAH) in congenital heart disease (CHD) with an isolated, large left-to-right shunt and to indicate the factors in the development of PAH. Methods. The pressure measurements in the cardiac chambers and the calculations based on the Fick's principle were compared among 3 separate groups of patients, respectively, with PAH, with hyperkinetic pulmonary hypertension (HPH), and with neither PAH nor HPH. Results. PAH was diagnosed in 30 (12.3%) patients, HPH in 35 (14.4%), while 177 (73.1%) were free of either. The highest risk for the development of PAH was found in the presence of perimembranous ventricular septal defect. A statistically significant difference was seen among these groups as to their left atrial pressure (p = 0.005) and the mean pulmonary arterial pressure (PAPmean; p < 0.001). While a correlation was present between RpI on one hand and age on the other (p = 0.014), a multiple linear regression could not evidence any correlation among age (p = 0.321), gender (p = 0.929). Conclusion. Our findings do not allow establishing a correlation between the duration of the high pulmonary flow and pulmonary vascular resistance increase or PAH development in isolated left-to-right shunts with congenital heart diseases. </p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2013 ","pages":"301617"},"PeriodicalIF":0.0,"publicationDate":"2013-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/301617","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31586299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Risk factors for coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapy. 冠状动脉药物洗脱支架血栓形成的危险因素:手术、患者、病变和支架相关因素的影响以及双重抗血小板治疗
Pub Date : 2013-06-23 Print Date: 2013-01-01 DOI: 10.1155/2013/748736
Krishnankutty Sudhir, James B Hermiller, Joanne M Ferguson, Charles A Simonton

The complication of stent thrombosis (ST) emerged at a rate of 0.5% annually for first-generation drug-eluting stents (DES), often presenting as death or myocardial infarction. Procedural factors such as stent underexpansion and malapposition are risk factors for ST in patients. The type of lesion being treated and lesion morphology also influence healing after treatment with DES and can contribute to ST. Second-generation DES such as the XIENCE V everolimus-eluting stent differ from the first-generation stents with respect to antiproliferative agents, coating technologies, and stent frame. Improvements in stent structure have resulted in a more complete endothelialization, thereby decreasing the incidence of ST. Bioresorbable scaffolds show promise for restoring vasomotor function and minimizing rates of very late ST. Post-PCI treatment with aspirin and clopidogrel for a year is currently the standard of care for DES, but high-risk patients may benefit from more potent antiplatelet agents. The optimal duration of DAPT for DES is currently unclear and will be addressed in large-scale randomized clinical trials.

第一代药物洗脱支架(DES)的支架血栓(ST)并发症发生率为每年0.5%,通常表现为死亡或心肌梗死。手术因素如支架扩张不足和错位是ST患者的危险因素。被治疗的病变类型和病变形态也会影响DES治疗后的愈合,并可能导致st。第二代DES,如XIENCE V依维莫司洗脱支架,在抗增殖药物、涂层技术和支架框架方面与第一代支架不同。支架结构的改进导致了更完全的内皮化,从而降低了st的发生率。生物可吸收支架有望恢复血管舒张功能,并将晚期st的发生率降至最低。pci后使用阿司匹林和氯吡格雷治疗一年是目前DES的标准治疗方案,但高风险患者可能受益于更有效的抗血小板药物。DAPT治疗DES的最佳持续时间目前尚不清楚,将在大规模随机临床试验中解决。
{"title":"Risk factors for coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapy.","authors":"Krishnankutty Sudhir,&nbsp;James B Hermiller,&nbsp;Joanne M Ferguson,&nbsp;Charles A Simonton","doi":"10.1155/2013/748736","DOIUrl":"https://doi.org/10.1155/2013/748736","url":null,"abstract":"<p><p>The complication of stent thrombosis (ST) emerged at a rate of 0.5% annually for first-generation drug-eluting stents (DES), often presenting as death or myocardial infarction. Procedural factors such as stent underexpansion and malapposition are risk factors for ST in patients. The type of lesion being treated and lesion morphology also influence healing after treatment with DES and can contribute to ST. Second-generation DES such as the XIENCE V everolimus-eluting stent differ from the first-generation stents with respect to antiproliferative agents, coating technologies, and stent frame. Improvements in stent structure have resulted in a more complete endothelialization, thereby decreasing the incidence of ST. Bioresorbable scaffolds show promise for restoring vasomotor function and minimizing rates of very late ST. Post-PCI treatment with aspirin and clopidogrel for a year is currently the standard of care for DES, but high-risk patients may benefit from more potent antiplatelet agents. The optimal duration of DAPT for DES is currently unclear and will be addressed in large-scale randomized clinical trials. </p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2013 ","pages":"748736"},"PeriodicalIF":0.0,"publicationDate":"2013-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/748736","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31586300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
A review of most relevant complications of transcatheter aortic valve implantation. 经导管主动脉瓣植入术的相关并发症综述。
Pub Date : 2013-05-12 Print Date: 2013-01-01 DOI: 10.1155/2013/956252
Siyamek Neragi-Miandoab, Robert E Michler

Transcatheter aortic valve implantation (TAVI) has emerged for treating aortic stenosis in patients who are poor candidates for surgical aortic valve replacement. Currently, the balloon-expandable Edwards Sapien valve-which is usually implanted via a transfemoral or transapical approach-and the self-expanding CoreValve ReValving system-which is designed for retrograde application-are the most widely implanted valves worldwide. Although a promising approach for high-risk patients, the indication may be expanded to intermediate- and eventually low-risk patients in the future; however, doing so will require a better understanding of potential complications, risk factors for these complications, and strategies to individualize each patient to a different access route and a specific valve. This paper reviews the most relevant complications that may occur in patients who undergo catheter-based aortic valve implantation.

经导管主动脉瓣植入术(TAVI)已经出现在治疗主动脉瓣狭窄的患者谁是不适合手术主动脉瓣置换术。目前,气囊式可膨胀Edwards Sapien瓣膜(通常通过经股骨或经根尖入路植入)和自膨胀CoreValve revalve系统(设计用于逆行应用)是世界上植入最广泛的瓣膜。虽然这种方法对高危患者很有希望,但将来可能会扩展到中危患者,最终扩展到低危患者;然而,这样做需要更好地了解潜在的并发症,这些并发症的危险因素,以及为每位患者提供不同的通路和特定瓣膜的个性化策略。本文综述了导管主动脉瓣植入术中可能出现的最相关并发症。
{"title":"A review of most relevant complications of transcatheter aortic valve implantation.","authors":"Siyamek Neragi-Miandoab,&nbsp;Robert E Michler","doi":"10.1155/2013/956252","DOIUrl":"https://doi.org/10.1155/2013/956252","url":null,"abstract":"<p><p>Transcatheter aortic valve implantation (TAVI) has emerged for treating aortic stenosis in patients who are poor candidates for surgical aortic valve replacement. Currently, the balloon-expandable Edwards Sapien valve-which is usually implanted via a transfemoral or transapical approach-and the self-expanding CoreValve ReValving system-which is designed for retrograde application-are the most widely implanted valves worldwide. Although a promising approach for high-risk patients, the indication may be expanded to intermediate- and eventually low-risk patients in the future; however, doing so will require a better understanding of potential complications, risk factors for these complications, and strategies to individualize each patient to a different access route and a specific valve. This paper reviews the most relevant complications that may occur in patients who undergo catheter-based aortic valve implantation. </p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2013 ","pages":"956252"},"PeriodicalIF":0.0,"publicationDate":"2013-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/956252","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31572051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 47
The Transaxial Orientation Is Superior to Both the Short Axis and Horizontal Long Axis Orientations for Determining Right Ventricular Volume and Ejection Fraction Using Simpson's Method with Cardiac Magnetic Resonance. 心脏磁共振辛普森法测定右心室容积和射血分数时,横轴位优于短轴位和水平长轴位。
Pub Date : 2013-04-14 Print Date: 2013-01-01 DOI: 10.1155/2013/268697
Michael K Atalay, Kevin J Chang, David J Grand, Shawn Haji-Momenian, Jason T Machan, Florence H Sheehan

We sought to determine which of the three orientations is the most reliable and accurate for quantifying right ventricular (RV) volume and ejection fraction (EF) by cardiac magnetic resonance using Simpson's method. We studied 20 patients using short axis (SA), transaxial (TA), and horizontal long axis (HLA) orientations. Three readers independently traced RV endocardial contours at end-diastole and end-systole for each orientation. End-diastolic volumes (EDVs), end-systolic volumes (ESVs), and EF were calculated and compared with the 3D piecewise smooth subdivision surface (PSSS) method. The intraclass correlation coefficients among the 3 readers for EDV, ESV, and EF were 0.92, 0.82, and 0.42, respectively, for SA, 0.95, 0.92, and 0.67 for TA, and 0.85, 0.93, and 0.69 for HLA. For mean data there was no significant difference between TA and PSSS for EDV (-2.6%, 95% CI: -8.2 to 3.3%), ESV (-5.9%, -15.2 to 4.5%), and EF (1.7%, -1.5 to 4.9%). HLA was accurate for ESV (-8.9%, -18.5 to 1.8%) and EF (-0.7%, -3.8 to 2.5%) but significantly underestimated EDV (-9.8, -16.6 to -2.4%). SA was accurate for EDV (0.5%, -6.0 to 7.5%) but overestimated ESV (10.5%, 0.1 to 21.9%) and had poor interrater reliability for EF. Conclusions. The TA orientation provides the most reliable and accurate measures of EDV, ESV, and EF.

我们试图确定三个方向中哪一个是最可靠和准确的量化右心室(RV)体积和射血分数(EF)的心脏磁共振使用辛普森的方法。我们采用短轴(SA)、跨轴(TA)和水平长轴(HLA)定向对20例患者进行了研究。三位读卡器分别在舒张末期和收缩期末期独立追踪左室心内膜轮廓。计算舒张末期体积(edv)、收缩末期体积(esv)和EF,并与3D分段光滑细分表面(PSSS)法进行比较。EDV、ESV和EF的类内相关系数分别为0.92、0.82和0.42,SA、TA的类内相关系数分别为0.95、0.92和0.67,HLA的类内相关系数分别为0.85、0.93和0.69。对于平均数据,TA和PSSS在EDV (-2.6%, 95% CI: -8.2至3.3%)、ESV(-5.9%, -15.2至4.5%)和EF(1.7%, -1.5至4.9%)方面没有显著差异。HLA对ESV(-8.9%, -18.5 ~ 1.8%)和EF(-0.7%, -3.8 ~ 2.5%)准确,但对EDV(-9.8, -16.6 ~ -2.4%)明显低估。SA对EDV准确(0.5%,-6.0 ~ 7.5%),但对ESV的估计过高(10.5%,0.1 ~ 21.9%),对EF的判读信度较差。结论。TA取向提供了最可靠和准确的EDV、ESV和EF测量。
{"title":"The Transaxial Orientation Is Superior to Both the Short Axis and Horizontal Long Axis Orientations for Determining Right Ventricular Volume and Ejection Fraction Using Simpson's Method with Cardiac Magnetic Resonance.","authors":"Michael K Atalay,&nbsp;Kevin J Chang,&nbsp;David J Grand,&nbsp;Shawn Haji-Momenian,&nbsp;Jason T Machan,&nbsp;Florence H Sheehan","doi":"10.1155/2013/268697","DOIUrl":"https://doi.org/10.1155/2013/268697","url":null,"abstract":"<p><p>We sought to determine which of the three orientations is the most reliable and accurate for quantifying right ventricular (RV) volume and ejection fraction (EF) by cardiac magnetic resonance using Simpson's method. We studied 20 patients using short axis (SA), transaxial (TA), and horizontal long axis (HLA) orientations. Three readers independently traced RV endocardial contours at end-diastole and end-systole for each orientation. End-diastolic volumes (EDVs), end-systolic volumes (ESVs), and EF were calculated and compared with the 3D piecewise smooth subdivision surface (PSSS) method. The intraclass correlation coefficients among the 3 readers for EDV, ESV, and EF were 0.92, 0.82, and 0.42, respectively, for SA, 0.95, 0.92, and 0.67 for TA, and 0.85, 0.93, and 0.69 for HLA. For mean data there was no significant difference between TA and PSSS for EDV (-2.6%, 95% CI: -8.2 to 3.3%), ESV (-5.9%, -15.2 to 4.5%), and EF (1.7%, -1.5 to 4.9%). HLA was accurate for ESV (-8.9%, -18.5 to 1.8%) and EF (-0.7%, -3.8 to 2.5%) but significantly underestimated EDV (-9.8, -16.6 to -2.4%). SA was accurate for EDV (0.5%, -6.0 to 7.5%) but overestimated ESV (10.5%, 0.1 to 21.9%) and had poor interrater reliability for EF. Conclusions. The TA orientation provides the most reliable and accurate measures of EDV, ESV, and EF.</p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2013 ","pages":"268697"},"PeriodicalIF":0.0,"publicationDate":"2013-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/268697","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31445437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Elevated cardiac troponins in setting of systemic inflammatory response syndrome, sepsis, and septic shock. 全身炎症反应综合征、败血症和感染性休克时肌钙蛋白升高。
Pub Date : 2013-04-11 Print Date: 2013-01-01 DOI: 10.1155/2013/723435
Nasir Hussain

Elevation of cardiac troponins and creatinine kinase is frequently observed in setting of systemic inflammatory response syndrome (SIRS), sepsis, or septic shock. Underlying pathophysiologic mechanism for such troponin leak, its clinical significance, and what different could be done in such settings remain elusive. In this paper we have briefly overviewed the proposed pathogenic mechanisms for SIRS, sepsis, or septic shock-related troponin elevation (SRTE) and have provided brief overview on its clinical significance. Upon review of the relevant literature we found that majority of patients with the SRTE with no prior history of coronary artery disease (CAD) upon testing are found not to have any CADs. We have also briefly discussed the possible pharmacologic agents and potential targets which are important from pathophysiologic and pharmacologic point of view that may alter the outcomes of SRTE-related myocardial depression in near future.

在全身炎症反应综合征(SIRS)、败血症或感染性休克的情况下,经常观察到心肌肌钙蛋白和肌酸酐激酶的升高。这种肌钙蛋白渗漏的潜在病理生理机制、临床意义以及在这种情况下可以做些什么仍然难以捉摸。在本文中,我们简要概述了SIRS、败血症或感染性休克相关肌钙蛋白升高(SRTE)的致病机制,并简要概述了其临床意义。在回顾相关文献后,我们发现大多数SRTE患者在测试时没有冠状动脉疾病(CAD)病史,但没有任何CAD。我们还简要讨论了可能的药理学药物和潜在靶点,这些药物从病理生理学和药理学的角度来看是重要的,可能在不久的将来改变SRTE相关心肌抑制的结果。
{"title":"Elevated cardiac troponins in setting of systemic inflammatory response syndrome, sepsis, and septic shock.","authors":"Nasir Hussain","doi":"10.1155/2013/723435","DOIUrl":"10.1155/2013/723435","url":null,"abstract":"<p><p>Elevation of cardiac troponins and creatinine kinase is frequently observed in setting of systemic inflammatory response syndrome (SIRS), sepsis, or septic shock. Underlying pathophysiologic mechanism for such troponin leak, its clinical significance, and what different could be done in such settings remain elusive. In this paper we have briefly overviewed the proposed pathogenic mechanisms for SIRS, sepsis, or septic shock-related troponin elevation (SRTE) and have provided brief overview on its clinical significance. Upon review of the relevant literature we found that majority of patients with the SRTE with no prior history of coronary artery disease (CAD) upon testing are found not to have any CADs. We have also briefly discussed the possible pharmacologic agents and potential targets which are important from pathophysiologic and pharmacologic point of view that may alter the outcomes of SRTE-related myocardial depression in near future.</p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2013 ","pages":"723435"},"PeriodicalIF":0.0,"publicationDate":"2013-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/723435","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31445438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
Dual antiplatelet therapy can be discontinued at three months after implantation of zotarolimus-eluting stent in patients with coronary artery disease. 双重抗血小板治疗可在冠状动脉疾病患者植入佐他莫司洗脱支架后3个月停止。
Pub Date : 2013-04-04 Print Date: 2013-01-01 DOI: 10.1155/2013/518968
Tadashi Wada, Makoto Nakahama, Hironobu Toda, Atsuyuki Watanabe, Katsushi Hashimoto, Ritsuko Terasaka, Kazufumi Nakamura, Nobuyuki Yamada, Hiroshi Ito

Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention increases the risk of bleeding. We studied the safety and clinical outcomes of switching from DAPT to aspirin monotherapy at 3 months after ZES implantation. We retrospectively evaluated 168 consecutive patients with coronary artery disease who had been implanted with a ZES from June 2009 through March 2010. After excluding 40 patients according to exclusion criteria such as myocardial infarction, 128 patients were divided into a 3-month DAPT group (67 patients, 88 lesions) and a 12-month conventional DAPT group (61 patients, 81 lesions). Coronary angiographic followup and clinical followup were conducted at more than 8 months and at 12 months after ZES implantation, respectively. Minor and major bleeding events, stent thrombosis (ST), and major adverse cardiac events (MACE) (death, myocardial infarction, cerebrovascular accident, target lesion revascularization, and target vessel revascularization) were evaluated. There were no statistically significant differences in the incidences of ST and MACE between the two groups. The incidence of bleeding events was significantly lower in the 3-month group than in the 12-month group (1.5% versus 11.5%, P < 0.05). DAPT can be safely discontinued at 3 months after ZES implantation, which reduces bleeding risk.

经皮冠状动脉介入治疗后双重抗血小板治疗(DAPT)增加出血的风险。我们研究了在植入ZES后3个月从DAPT转为阿司匹林单药治疗的安全性和临床结果。从2009年6月至2010年3月,我们回顾性评估了168例连续植入了ZES的冠状动脉疾病患者。根据心肌梗死等排除标准排除40例患者后,128例患者分为3个月DAPT组(67例,88个病变)和12个月常规DAPT组(61例,81个病变)。分别于植入后8个月及12个月进行冠状动脉造影随访及临床随访。评估轻微和严重出血事件、支架血栓形成(ST)和主要心脏不良事件(MACE)(死亡、心肌梗死、脑血管意外、靶病变血运重建术和靶血管血运重建术)。两组间ST和MACE发生率无统计学差异。3个月组出血事件发生率明显低于12个月组(1.5% vs 11.5%, P < 0.05)。DAPT可以在植入ZES后3个月安全停用,从而降低出血风险。
{"title":"Dual antiplatelet therapy can be discontinued at three months after implantation of zotarolimus-eluting stent in patients with coronary artery disease.","authors":"Tadashi Wada,&nbsp;Makoto Nakahama,&nbsp;Hironobu Toda,&nbsp;Atsuyuki Watanabe,&nbsp;Katsushi Hashimoto,&nbsp;Ritsuko Terasaka,&nbsp;Kazufumi Nakamura,&nbsp;Nobuyuki Yamada,&nbsp;Hiroshi Ito","doi":"10.1155/2013/518968","DOIUrl":"https://doi.org/10.1155/2013/518968","url":null,"abstract":"<p><p>Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention increases the risk of bleeding. We studied the safety and clinical outcomes of switching from DAPT to aspirin monotherapy at 3 months after ZES implantation. We retrospectively evaluated 168 consecutive patients with coronary artery disease who had been implanted with a ZES from June 2009 through March 2010. After excluding 40 patients according to exclusion criteria such as myocardial infarction, 128 patients were divided into a 3-month DAPT group (67 patients, 88 lesions) and a 12-month conventional DAPT group (61 patients, 81 lesions). Coronary angiographic followup and clinical followup were conducted at more than 8 months and at 12 months after ZES implantation, respectively. Minor and major bleeding events, stent thrombosis (ST), and major adverse cardiac events (MACE) (death, myocardial infarction, cerebrovascular accident, target lesion revascularization, and target vessel revascularization) were evaluated. There were no statistically significant differences in the incidences of ST and MACE between the two groups. The incidence of bleeding events was significantly lower in the 3-month group than in the 12-month group (1.5% versus 11.5%, P < 0.05). DAPT can be safely discontinued at 3 months after ZES implantation, which reduces bleeding risk.</p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2013 ","pages":"518968"},"PeriodicalIF":0.0,"publicationDate":"2013-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/518968","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31503619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Hyperoxic vasoconstriction of human pulmonary arteries: a novel insight into acute ventricular septal defects. 人肺动脉的高氧血管收缩:对急性室间隔缺损的新见解。
Pub Date : 2013-03-31 Print Date: 2013-01-01 DOI: 10.1155/2013/685735
Priyadharshanan Ariyaratnam, Mahmoud Loubani, Robert Bennett, Steven Griffin, Mubarak A Chaudhry, Michael E Cowen, Levant Guvendik, Alexander R J Cale, Alyn H Morice

Objectives. Acute rises in pulmonary artery pressures following postinfarction ventricular septal defects present a challenge. We hypothesised that the abnormally high oxygen content exposure to the pulmonary arteries may be a factor. We investigated the contractile responses of human pulmonary arteries to changes in oxygen tension. Methods. Isometric tension was measured in large and medium sized pulmonary artery rings obtained from lung resections for patients with bronchial carcinoma (n = 30). Fresh rings were mounted in organ baths bubbled under basal conditions with hyperoxic or normoxic gas mixes and the gas tensions varied during the experiment. We studied whether voltage-gated calcium channels and nitric oxide signalling had any role in responses to oxygen changes. Results. Hypoxia caused a net mean relaxation of 18.1% ± 15.5 (P < 0.005) from hyperoxia. Subsequent hyperoxia caused a contraction of 19.2% ± 13.5 (P < 0.005). Arteries maintained in normoxia responded to hyperoxia with a mean constriction of 14.8% ± 3.9 (P < 0.005). Nifedipine inhibited the vasoconstrictive response (P < 0.05) whilst L-NAME had no effect on any hypoxic vasodilatory response. Conclusions. We demonstrate that hyperoxia leads to vasoconstriction in human pulmonary arteries. The mechanism appears to be dependent on voltage-gated calcium channels. Hyperoxic vasoconstriction may contribute to acute rises in pulmonary artery pressures.

目标。梗死后室间隔缺损肺动脉压的急性升高是一个挑战。我们假设肺动脉暴露的异常高氧含量可能是一个因素。我们研究了人肺动脉对氧张力变化的收缩反应。方法。对支气管癌患者肺切除术后获得的大、中大小肺动脉环进行等距张力测量(n = 30)。在高氧或常氧混合气体的基础条件下,将新鲜环安装在起泡的器官浴中,并在实验过程中改变气体张力。我们研究了电压门控钙通道和一氧化氮信号是否在对氧变化的反应中起任何作用。结果。低氧导致高氧的净平均松弛18.1%±15.5 (P < 0.005)。随后的高氧导致收缩19.2%±13.5 (P < 0.005)。维持在常氧状态下的动脉对高氧反应平均收缩14.8%±3.9 (P < 0.005)。硝苯地平对血管收缩反应有抑制作用(P < 0.05),而L-NAME对缺氧血管扩张反应无影响。结论。我们证明了高氧导致人肺动脉血管收缩。其机制似乎依赖于电压门控钙通道。高氧血管收缩可导致肺动脉压的急性升高。
{"title":"Hyperoxic vasoconstriction of human pulmonary arteries: a novel insight into acute ventricular septal defects.","authors":"Priyadharshanan Ariyaratnam,&nbsp;Mahmoud Loubani,&nbsp;Robert Bennett,&nbsp;Steven Griffin,&nbsp;Mubarak A Chaudhry,&nbsp;Michael E Cowen,&nbsp;Levant Guvendik,&nbsp;Alexander R J Cale,&nbsp;Alyn H Morice","doi":"10.1155/2013/685735","DOIUrl":"https://doi.org/10.1155/2013/685735","url":null,"abstract":"<p><p>Objectives. Acute rises in pulmonary artery pressures following postinfarction ventricular septal defects present a challenge. We hypothesised that the abnormally high oxygen content exposure to the pulmonary arteries may be a factor. We investigated the contractile responses of human pulmonary arteries to changes in oxygen tension. Methods. Isometric tension was measured in large and medium sized pulmonary artery rings obtained from lung resections for patients with bronchial carcinoma (n = 30). Fresh rings were mounted in organ baths bubbled under basal conditions with hyperoxic or normoxic gas mixes and the gas tensions varied during the experiment. We studied whether voltage-gated calcium channels and nitric oxide signalling had any role in responses to oxygen changes. Results. Hypoxia caused a net mean relaxation of 18.1% ± 15.5 (P < 0.005) from hyperoxia. Subsequent hyperoxia caused a contraction of 19.2% ± 13.5 (P < 0.005). Arteries maintained in normoxia responded to hyperoxia with a mean constriction of 14.8% ± 3.9 (P < 0.005). Nifedipine inhibited the vasoconstrictive response (P < 0.05) whilst L-NAME had no effect on any hypoxic vasodilatory response. Conclusions. We demonstrate that hyperoxia leads to vasoconstriction in human pulmonary arteries. The mechanism appears to be dependent on voltage-gated calcium channels. Hyperoxic vasoconstriction may contribute to acute rises in pulmonary artery pressures.</p>","PeriodicalId":73519,"journal":{"name":"ISRN cardiology","volume":"2013 ","pages":"685735"},"PeriodicalIF":0.0,"publicationDate":"2013-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/685735","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31376567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
期刊
ISRN cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1